Clinical Trial Update: Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KW-6500 in Parkinson's disease patients with motor response complications on levodopa therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• KW-6500

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED